AI Index / Schrödinger, Inc.
Schrödinger, Inc. (SDGR)
Schrödinger, a company specializing in computational platforms for molecular discovery, integrates advanced machine learning into its software to enhance drug discovery processes. This includes initiatives like predictive toxicology, supported by a $10 million grant from the Gates Foundation, aiming to anticipate toxicological risks early in drug development.
Loading...
We are also pleased to see wide recognition that simulated data is required to realize the full potential of AI and drug discovery.
- Ramy Farid
Similar Companies in the Swift AI Index
Quotes from schrdinger Executives About Artificial Intelligence and Generative AI
To effectively harness AI and machine learning for molecular discovery, vast amounts of high-quality physics-based simulation data are essential for training robust AI models.
- Ramy Farid
With this new computational physics plus AI paradigm becoming the accepted standard, we are very optimistic about the long-term potential and value of our platform.
- Ramy Farid
We leverage structural biology breakthroughs and physics combined with the power and speed of AI to enable broad exploration of chemical space to identify novel molecules that repeatedly meet a wide range of product profiles.
- Karen Akinsanya
These Phase IIb and III assets represent the most advanced examples of medicines designed by leveraging large-scale use of our physics-based methods, along with AI and machine learning.
- Karen Akinsanya
We are at the forefront of this paradigm shift. We believe our technological advantages, combined with the strategic actions we have taken to improve our operational efficiency and long-term profitability profile, will position us to deliver growth in the years to come.
- Ramy Farid